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Introduction: Patients with stage III and IV pressure ulcers requiring surgical reconstruction remain a challenge.
Extended hospitalization, and high costs of care per patient episode due to high rates of complications and
recurrence, make efforts to reduce these rates of utmost importance to the medical community in general. We
report a case in which two prior attempts at surgical resolution had failed, and which was successfully resolved
with the aid of a new tissue adhesive designed for the closure of dead space. To the best of our knowledge, this is
the first reported example of the use of this adhesive in flap surgery for pressure ulcers.
Case presentation: We report the case of a 42-year-old Caucasian wheelchair-bound paraplegic man with history
of spina bifida, urinary catheter, colostomy, and a history of pressure ulcers. He presented to our institution with a
stage IV, methicillin-resistant Staphylococcus aureus-contaminated pressure sore on his left ischial tuberosity. A first
procedure using V-Y and rotational flap closure dehisced on postoperative day three due to his excessive movement. A
second procedure was performed but this also required revision due to dehiscence related to fluid accumulation under
the flap. A third procedure using TissuGlu® Surgical Adhesive to adhere the flap and close the dead space resulted in
successful resolution. At his last follow-up appointment at seven weeks post-operation he was healing well and was
back in his wheelchair.
Conclusions: Any reductions in hospital stay, complication rates, or recurrence rates would be important in this highly
problematic group of patients. Elimination of the dead space where fluids can accumulate, combined with adhesion of
the flaps with a sufficient strength to withstand the shear forces commonly encountered, could represent an important
advancement in the treatment of pressure ulcers requiring surgical repair with myocutaneous or fasciocutaneous flaps.
Our initial experience in this case suggests that TissuGlu® may be able to help reduce recurrence rates in this
challenging group of patients.
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Late-stage pressure ulcers requiring surgical coverage
with flaps are common. Various flap techniques have
proven effective for defect coverage, but these continue
to have high complication and recurrence rates [1-5],
leading to additional patient discomfort, scheduling, and
management issues for surgical teams and overall high
costs of care and treatment [6-8].
Though there is no source for statistics on worldwide
procedure volumes, in the United States over 238,000
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ported the average cost for treatment of stage IV pres-
sure ulcers and related complications in 19 patients in
New York at $125,000 to $130,000, emphasizing that ‘in
calculating costs, the amount spent on treating associ-
ated medical complications of pressure ulcers must also
be included’ [8].
As these patients require substantially more nursing
resources than others, our department is forced to limit
the number of these cases admitted, so as not to over-
burden the staff; handling more than two of these pa-
tients at a time becomes logistically challenging.
Complication and recurrence rates are high, driving
the costs and resource usage cited above. In a systematic
review of the literature on flap surgeries for treatment of
pressure sores, Sameem et al. reported mean complica-
tion rates for myocutaneous flaps at 18.6%, fasciocuta-
neous flaps at 11.7%, and perforator-based flaps 19.6%,
while recurrence rates for the same three groups were
8.9%, 11.2%, and 5.6%, respectively [1]. Other studies
have reported complication and recurrence rates of up
to 54% and 61%, respectively [2,9].
The most commonly cited factor in complications and
recurrence is wound dehiscence, generally associated
with persistent dead space in the wound cavity, shear
forces on the tissue planes, and accumulation of serous
fluids [1]. Elimination (closure) of the dead space is crit-
ical to effective healing, but this is not always easy or
possible to obtain with previously described techniques
or technologies.
Given the generally poor vascularization and overall
tissue quality, suturing techniques to approximate the
flaps are usually not an option in pressure sore repair.
Filling the dead space with a ‘double adipofascial turn-
over flap’ has been suggested [10], and may have applica-
tion in some surgical procedures. It has also been
suggested that fibrin sealants may be effective in facili-
tating wound healing with fasciocutaneous flaps [11].
Erba et al. identified a reduced rate of drainage volume
in the first postoperative days in the fibrin sealant group
[11]. Given that fibrin-based products remain in the
wound only for the first one to two days, it is unlikely
that these could have an effect on the longer term heal-
ing process, where the tissue planes need to be held in
approximation for a period of weeks rather than days.
Early postoperative drainage volume is unlikely to be a
useful indicator of successful wound healing.
A new adhesive technology recently introduced in
Germany (TissuGlu® Surgical Adhesive, Cohera Medical,
Inc. [Pittsburgh, USA]), is indicated for ‘approximation
of tissue layers where subcutaneous dead space exists
between the tissue planes in large flap surgical proce-
dures such as abdominoplasty’. Reports on the use of
this technology in abdominoplasty suggest that it caneliminate the need for surgical drains in those proce-
dures (Michaels J, unpublished work). Reduced compli-
cations and reduced revision rates in inguinal lymph
node dissection have also been presented (Stollwerck L,
unpublished work). In latissimus dorsi donor site closure
at least one group has reported positive experiences in a
very challenging patient population, repair of defects re-
lated to sternal osteomyelitis (Reutemann M, unpub-
lished work), and several groups have reported on their
use of the technology in mastectomy for closure of the
flap, in some cases without drain placement [12-14].
Given the mechanism of action described, and the chal-
lenges faced in patients with recurrent stage IV pressure
sores, we decided to use it to assist with wound closure
in a revision flap procedure.
Case presentation
We report the case of a 42-year-old Caucasian
wheelchair-bound paraplegic man with spina bifida who
had had surgical treatments over the most recent few
years for pressure sores on both the ischial and sacral re-
gions. A supra pubic catheter was placed in 2005 and a
colostomy was performed to improve the care after he
had suffered from a sacral pressure sore. He was admit-
ted to our clinic because of a stage IV pressure ulcer on
his left tuber ischiadicum. The microbiological examin-
ation of his wound showed a contamination with
methicillin-resistant Staphylococcus aureus. His blood
test revealed an elevation of inflammatory parameters
(14.17×103/μL leucocytes, CRP [C-reactive protein]
10.04mg/dL) and a slightly low protein level at 6.4g/dL.
We decided to do a one-stage surgical procedure of
debridement and flap coverage using a V-Y procedure
and a rotational flap for wound closure. The operation
was performed the day after he was admitted to our
hospital. We decided not to treat him with antibiotics
at this point.
Three days after the first surgical procedure his wound
developed a dehiscence due to his excessive movement.
A revision, with debridement and surgical closure of the
wound, was performed. There were no signs of infection
and the results of his blood test showed that the inflam-
matory parameters were decreasing. The drains showed
minor quantities of clear fluid.
On the eighth day after the second surgery there was a
small amount of fluid in his wound dressing, even
though the drains were still in place. A new dehiscence
of his wound led to a third surgical procedure on day 15
after the first operation. As there was considerable
dead space below the flaps we decided, after a de-
bridement and an analysis of his wound situation, to
reduce the dead space and hold the flaps in place by
using TissuGlu® Surgical Adhesive. This involved the
application of a grid pattern of adhesive to the tissue
Figure 2 The end of the application. The application device
allowed the placement of a grit pattern of defined amounts of glue
to the wound.
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measured amounts in a row of three droplets at a time
(Figures 1 and 2). The tissue flap was then positioned,
attempting to avoid smearing of the grid of drops, and
sutured in place as normal. The application of the adhe-
sive took no more than two minutes.
There were no further complications with this pres-
sure sore. He was dismissed 17 days after the last pro-
cedure. At seven weeks after the last procedure, he was
healing well and was allowed to sit in his wheelchair
again.
Discussion
In a recently concluded retrospective review of 23 pa-
tients at our own institution who underwent stage III
and IV pressure sore repair with myocutaneous and fas-
ciocutaneous flaps, we found that eight (34.8%) required
revision surgery, with three of these requiring two or
more procedures. While not inconsistent with the rates
reported in the literature, this need for revision surgeries
represents an enormous burden on the patients and
their families, as well as on the healthcare system and
hospital staff.
As part of our efforts to seek techniques or technolo-
gies to reduce this recurrence rate, we have analyzed the
primary causative factors leading to the need for revision
procedures. The underlying, often systemic, wound-
healing deficits are exacerbated by two factors: 1) shear
forces which cause movement of the flap with respect to
the underlying tissue, thereby impeding or interrupting
the formation of a collagen matrix; and 2) the accumula-
tion of fluids in the dead space between the tissue
planes, which leads to a physical separation of the
planes, thereby preventing tissue repair and normal heal-
ing. Our search for solutions has therefore been focused
on approaches which can effectively hold the two
planes in close approximation for the duration of theFigure 1 Pressure sore debrided and rotational flap elevated.
The surgical adhesive is applied to the wound.proliferative phase of wound healing; often signifi-
cantly longer in pressure sore patients than the 3 to
21 days normally cited for this phase.
Fibrin-based technologies have been extensively stud-
ied and have not been shown to be as effective as adhe-
sives for large flap fixation. The facts that the fibrin clots
formed do not have a high shear strength and are gener-
ally broken down within a few days through fibrinolysis
suggest that they may be inappropriate for this particular
indication. Techniques of mechanical closure such as
quilting sutures have also been studied by many and
have generally been found to be effective. Suturing tech-
niques, however, are often not feasible in these wounds
due to compromised tissue quality, poor vascularization,
and the risk of focal point necrosis. A high-strength tis-
sue adhesive which is biocompatible, non-inflammatory,
resorbable, and with a duration of effect of several weeks
would correspond to the need.
The adhesive in question is a one-part lysine-based ur-
ethane pre-polymer which cures in the presence of
moisture. It is applied immediately prior to flap closure
using a custom applicator which delivers precisely mea-
sured droplets in a grid pattern on the substrate tissue
plane. The adhesive drops begin curing on contact with
moisture but the process is slow, taking up to 45 to
50 minutes to reach full strength. There is, therefore, no
need to rush the process of flap closure. Care should be
taken to avoid smearing the drops during closure, and
then gentle pressure is applied across the entire flap sur-
face to ensure contact and elimination of dead space.
Care must also be taken to avoid pulling the flap as the
suture knots are tied, and to avoid any other movement
that could interrupt the bonds during the first 40 to
50 minutes after application.
The fully polymerized adhesive droplets maintain their
properties of adherence to the tissue for between four
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through a process of hydrolysis into lysine, CO2,
and very small amounts of alcohol and polyols (sugar
alcohols). Complete resorption can take as long as
24 months. In the event that the revision of a flap is re-
quired, drops of adhesive are likely to be identifiable in
the wound bed and can be separated from the tissue
plane without damage. Re-application of the product in
the secondary closure would not be recommended.
Conclusions
Our case report suggests that this new kind of adhesive
may be helpful in attempts to reduce the rates of recur-
rence and complications in myocutaneous and fasciocu-
taneous flap surgery for late-stage pressure sores. The
application is fast and the costs are acceptable, especially
if a recurrence can be prevented. An ongoing prospect-
ive series currently being done in our facility will add
additional evidence to help evaluate this hypothesis. Fur-
ther studies will be required before any definitive state-
ments can be made, but the evidence of efficacy of the
device in other flap procedures, combined with the logic
of closing dead space with points of adhesive, give us
reason to be optimistic.
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